SCHEMBL453914

SCHEMBL453914

SCc1ccsc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexane SCHEMBL28208368 0.87 DRD2 (0.47)
SCHEMBL7279542 0.79
SCHEMBL8671494 0.77 TAAR1 (0.71)
SCHEMBL9746802 0.75
SCHEMBL13123465 0.74
SCHEMBL120232 0.72
SCHEMBL453909 0.72
SCHEMBL1309263 0.72
SCHEMBL9855401 0.72 TAAR1 (0.65)
SCHEMBL479477 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112321976-A Processing method of thermally stable plastic 李世兵 2021-02-05 CN claimed
CN-104370937-B The synthetic method and purposes of a kind of containing oxygen group elements and five condensed ring conjugated molecules and its derivative 浙江华显光电科技有限公司 2018-04-10 CN claimed
CN-105360157-A Pesticide particulate agent containing acetamiprid and deltamethrin NANNING SUIZHONG FUYU TECH DEV CO LTD 2016-03-02 CN claimed
CN-105340955-A Pesticide composition containing thifluzamide and chlorpyrifos NANNING SUICONG FUYU TECHNOLOGY DEV CO LTD 2016-02-24 CN claimed
CN-104370937-A Oxygen family element-containing penta-condensed ring conjugated molecule and its derivative synthetic method and purpose thereof ZHEJIANG OUPU PHOTOELECTRIC TECHNOLOGY CO LTD 2015-02-25 CN claimed
EP-4447944-A1 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF THERAPEUTIC AND/OR DIAGNOSTIC SPECIES THE PENN STATE RESEARCH FOUNDATION (US) 2024-10-23 EP disclosed
US-20240335540-A1 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF THERAPEUTIC AND/OR DIAGNOSTIC SPECIES PENN STATE RES FOUND (US) 2024-10-10 US disclosed
CN-118613287-A Compositions and methods for targeted delivery of therapeutic and/or diagnostic substances 宾夕法尼亚州立大学研究基金会 2024-09-06 CN disclosed
EP-3861001-B1 BORON CONTAINING PDE4 INHIBITORS PFIZER (US) 2023-12-13 EP disclosed
CN-117127413-A Antistatic anti-electromagnetic radiation coated fabric and preparation method thereof 南通全技纺织涂层有限公司 2023-11-28 CN disclosed
WO-2023114466-A1 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF THERAPEUTIC AND/OR DIAGNOSTIC SPECIES THE PENN STATE RESEARCH FOUNDATION (US) 2023-06-22 WO disclosed
US-20230148402-A1 Boron Containing PDE4 Inhibitors PFIZER INC. (US) 2023-05-11 US disclosed
WO-2005030734-A1 DIAMINOPYRIMIDINE DERIVATIVES AS SELECTIVE GROWTH HORMONE SECRECTGOGUE RECEPTOR (GHS-R) ANTAGONISTS ABBOTT LABORATORIES (US) 2005-04-07 WO disclosed
US-20050070712-A1 Pyrimidine derivatives as ghrelin receptor modulators ABBOTT LABORATORIES 2005-03-31 US disclosed
EP-0588785-A1 UREA BASED LIPOXYGENASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1994-03-30 EP disclosed
US-5185363-A Administering for treatment of inflammatory diseases ABBOTT LABORATORIES (US) 1993-02-09 US disclosed
EP-0588785-A4 UREA BASED LIPOXYGENASE INHIBITING COMPOUNDS. ABBOTT LAB (US) 1991-12-30 EP disclosed
WO-1990012008-A1 UREA BASED LIPOXYGENASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1990-10-18 WO disclosed
US-4837316-A ANTIULCER AGENTS FUJIREBIO KABUSHIKI KAISHA (JP) 1989-06-06 US disclosed
EP-0214823-A2 Alkylamide derivatives with H2-receptor antagonistic and cytoprotective action FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) 1987-03-18 EP disclosed